Beyond Raw Materials: Building Partnerships That Drive Cell Therapy Innovation

As a cell therapy advances from early-stage research to commercial-scale manufacturing, the challenges extend far beyond sourcing GMP-grade raw materials. Success depends on strategic partnerships that ensure quality, consistency, and regulatory compliance while enabling scalability and cost efficiency.

This discussion will explore how collaborative supplier-developer models address critical pain points—from mitigating batch variability and navigating GMP transitions to strengthening supply chain resilience and supporting global regulatory requirements. Learn how these partnerships accelerate timelines, reduce risk, and unlock innovation in cell therapy manufacturing.